Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Slow titration is the key strategy for prevention
Weight loss as monotherapy is minimal, averaging 2-4 additional pounds monthly versus placebo in controlled settings
Keep older vials at the front or top of storage containers where they will be accessed first
This triple-hormone mechanism is one of the key differences between retatrutide and other medical weight loss peptides currently available, such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1 and GIP receptor agonist), and is one reason it has attracted so much attention in clinical obesity research
And thats exactly what I advocated for when I spoke before the committee
